Internet for Pharmaceutical and Biotech Communities
| Newsletter | Post Jobs | Advertising |
 
 

 

  

Pharm/Biotech Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

FDA Links

FDA Warning Letters

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 
 
   


Patent Classification

Pharmaceutical Manufacturing

  1. Method for large scale plasmid purification 
     
  2. Continuous manufacturing method for microspheres and apparatus
     
  3. Method and an industrial process for determining dose-level characteristics of a multiple unit system
     
  4. Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
     
  5. Manufacturing method for intraveneously administrable immune globulin and resultant product
     
  6. Method of producing a vitamin product
     
  7. Sterilization process for pharmaceutical suspensions
     
  8. Preparation of protein microparticles by supercritical fluid precipitation
     
  9. Making dosage units using low shear granulation
     
  10. Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
     
  11. Method for removing high boiling solvents from drug formulations by vacuum drying
     
  12. Process for the treatment of aspartame
     
  13. Large scale production process with instantaneous component mixing and controlled sequential mixing characteristics
     
  14. Processing of an elastomer dispersion
     
  15. Water-thin emulsion formed by high pressure homogenization process
     
  16. Process for producing drug-containing microspheres by oil-in-water evaporation process
     
  17. Process for the production of granules, and granules thus obtained
     
  18. Adhesive matrix type transdermal patch and method of manufacturing same
     
  19. Method for size separation of particles
     
  20. Continuous microsphere process
     
  21. Process to manufacture implants containing bioactive peptides
     
  22. Process for the dispersion by high-pressure homogenization of pulverulent fillers in a vehicle composed of at least one fatty phase, compositions obtained and uses
     
  23. Process for producing pharmaceutical preparations having a higher content of active plant ingredient
     
  24. Process for forming chewable quickly dispersing comestible unit and product therefrom

Pharmaceutical Manufacturing, Antibodies/Immunoglobulins

  1. Method of providing a purified, virus safe antibody preparation
     
  2. Methods for chemically synthesizing immunoglobulin chimeric proteins
     
  3. Stabilization of immunoglobulins at low pH
     
  4. Method for preparing human immunoglobulin concentrates for therapeutic use
     
  5. Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
     
  6. Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents
     
  7. Transgenic non-human animals capable of producing heterologous antibodies
     
  8. Method for producing monoclonal antibodies
     
  9. Method of use of transgenic plant expressed antibodies
     
  10. Method for making humanized antibodies
     
  11. Process for isolating IgG and IgA
     
  12. Method for the separation and purification of immunoglobulins
     
  13. Method of making monoclonal antibodies using polymorphic transgenic animals

Pharmaceutical Manufacturing, Blood/Blood Related Products

  1. Factor VIII/vWF-complex and methods of purifying same
     
  2. Viral reduction method for plasma using a leukocyte-reduction filter and two virus-reduction filters of decreasing pore diameters
     
  3. Method and apparatus for preparing an acellular red blood cell substitute
     
  4. Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
     
  5. Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
     
  6. Method for determination of platelets quality
     
  7. Blood substitutes
     
  8. Methods for sterilizing preparations containing albumin
     
  9. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
     
  10. Method for preparing human immunoglobulin concentrates for therapeutic use
     
  11. Lyophilization of human platelets
     
  12. Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
     
  13. Storage-stable, liquid fibrinogen formulation
     
  14. Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use
     
  15. Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution
     
  16. Method of filtering viruses from a factor VIII solution
     
  17. Acellular red blood cell substitute
     
  18. Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
     
  19. Process for the production of virus-inactivated human gammaglobulin G
     
  20. Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin
     
  21. Process for the purification of serum albumin
     
  22. Method for improving oxygen transport by stored red blood cells
     
  23. Low oxygen affinity mutant hemoglobins
     
  24. System for detecting bacteria in blood, blood products, and fluids of tissues
     
  25. Methods of production and use of liquid formulations of plasma proteins
     
  26. Physiologically acceptable aqueous solutions and methods for their use
     
  27. Fibrin nanoparticles and uses thereof
     
  28. Method and apparatus for preparing an acellular red blood cell substitute
     
  29. Method of the inactivation of viruses by a solvent-detergent combination and nanofiltration
     
  30. Transfusable oxygenating composition
     
  31. Analysis and separation of platelet-derived growth factor proteins
     
  32. Purification process for production of mannan-binding lectin and an MBL medicinal product
     
  33. Use of hemoglobin derivatives for determining plasma and/or blood volume
     
  34. Separation of antithrombin III .alpha. and .beta. variants by cyclodextrin-modified micellar electrokinetic chromatography

  35. Process for inactivating viruses in blood and blood products

  36. Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X

  37. Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
     
  38. Method for cryopreservation and recovery of red blood cells
     
  39. Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate

Pharmaceutical Manufacturing, Cell Culture/Virus

  1. Method of producing infectious reovirus
     
  2. Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
     
  3. Selective precipitation of viruses
     
  4. Preparation for use in cell culture in which an interfering compound is absent or depleted
     
  5. Method for large scale plasmid purification 
     
  6. Method for the production and purification of adenoviral vectors

Pharmaceutical Manufacturing, Crystallization

  1. Systems and methods for the generation of crystalline polymorphs
     
  2. Suplatast tosilate crystals
     
  3. Small particle-adjustment crystallization process
     
  4. Crystal forms of azithromycin
     
  5. Stable shaped particles of crystalline organic compounds
     
  6. Stable shaped particles of crystalline organic compounds
     
  7. Crystallization using supercritical or subcritical fluids
     
  8. Crystalline trimetrexate salts and the process for making the same

Pharmaceutical Manufacturing, Extrusion

  1. Continuous melt spheronization apparatus and process for the production of pharmaceutical pellets
     
  2. Melt-extruded orally administrable opioid formulations
     
  3. Melt-extrusion multiparticulates
     
  4. Effervescent granules and methods for their preparation
     
  5. Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process

  6. Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization

  7. Melt-extrusion multiparticulates
     
  8. Gastric remaining preparation, swollen molding, and production process
     
  9. Melt-extruded orally administrable opioid formulations
     
  10. Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt
     
  11. Healthful dissolvable oral tablets, and mini-bars
     
  12. Production of solid drug forms
     
  13. Extruded multi-particulates
     
  14. Extruded orally administrable opioid formulations
     
  15. Solid active extrusion compound preparations containing low-substituted hydroxypropylcellulose

Pharmaceutical Manufacturing, Fermentation

  1. Device and method for the production of biologically active compounds by fermentation
     
  2. Purification of microbial cell fermentation homogenates
     
  3. Process for the fermentative production of amino acids using coryneform bacteria in which OpcA gene expression is amplified
     
  4. Method of producing a compound by fermentation
     
  5. Fermentation process
     
  6. Method for evaluating an optimal dosage of defoamers in a fermentation process
     
  7. Fermentation process using specific oxygen uptake rates as a process control
     
  8. Product removal process for use in a biofermentation system
     
  9. Process for the production of L-amino acids by fermentation using coryneform bacteria
     
  10. Crystal harvest from fermentation broth
     
  11. Method for preparing steroids modified by yeast fermentation
     
  12. Process of purifying vancomycin hydrochloride
     
  13. Process for producing a product containing antihypertensive tripeptides
     
  14. Method for producing L-glutamic acid by fermentation
     
  15. Use of solutions containing enzymes for cleaning fermentation or storage tanks
     
  16. Fermentation method with continuous mass cultivation of ciliates (protozoa) for producing biogenous valuable substances
     
  17. Metabolically engineered lactic acid bacteria and their use
     
  18. Method for propagating fungi using solid state fermentation
     
  19. Reducing corrosion in a fermentor by providing sodium with a non-chloride sodium salt

Pharmaceutical Manufacturing, Freeze Drying

  1. Freeze-dried composition of inactivated virus envelope with membrane fusion activity
     
  2. Freeze-dried FSH/LH formulations
     
  3. Vibrio cholerae with improved biological safety features in freeze dried form
     
  4. Method for freeze-drying nucleic acid/block copolymer/ cationic surfactant complexes
     
  5. Freeze-dried pharmaceutical preparation
     
  6. Micronized freeze-dried particles
     
  7. Freeze-dried hepatitis A attenuated live vaccine and its stabilizer
     
  8. Stabilizer for pharmacons
     
  9. Freeze-dried pantoprazole preparation and pantoprazole injection
     
  10. Method of producing sub-micron particles of biologically active agents and uses thereof
     
  11. Formulation containing a nucleotide analogue
     
  12. Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
     
  13. Freeze-dried disintegrating tablets
     
  14. Process for preparing fast dispersing solid oral dosage form

Pharmaceutical Manufacturing, Immunoglobulin

  1. Processes for production of immunoglobulin A in milk
     
  2. Secretory immunoglobulin produced by single cells and methods for making and using same

Pharmaceutical Manufacturing, Interferon

  1. Population of interferon producing cells
     
  2. Methods for enhancing the production of interferon in cell culture
     
  3. Interferon-gamma (IFN-.gamma.) inducing factor (IGIF, IL-18) and peptide fragment thereof

Pharmaceutical Manufacturing, Lyophilization

  1. Concentrated protein lyophilates, methods, and uses
     
  2. Processes of making and using pharmaceutical formulations of antineoplastic agents
     
  3. Stable lyophilized pharmaceutical formulation of IgG antibodies
     
  4. IL-1 antagonist formulations
     
  5. Lyophilization of human platelets
     
  6. Formulation solubilizing water-insoluble agents and preparation method thereof
     
  7. Reduced-viscosity concentrated protein formulations
     
  8. Preparation and use of oligopeptide lyophilisate for gonad protection
     
  9. Preparation of submicron sized nanoparticles via dispersion lyophilization
     
  10. Protein formulation
     
  11. Lyophilizate of lipid complex of water insoluble porphyrins
     
  12. Lyophilizate of lipid complex of water insoluble camptothecins
     
  13. Excipient for the lyophilization of aqueous suspensions of microparticles
     
  14. Peptide/lipid complex formation by co-lyophilization
     
  15. Stable transglutaminase preparations and processes for their production
     
  16. Lyophilized platelet composition containing chloroquine, hydroxychloroquine, camoquin, quinacrine or procaine
     
  17. Biodegradable microparticles for the sustained delivery of therapeutic drugs
     
  18. Method for lyophilizing ifosfamide

Pharmaceutical Manufacturing, Micronization

  1. Progestin co-micronized with a surfactant pharmaceutical composition comprising same methods for making same and uses thereof
     
  2. Milling process for the production of finely milled medicinal substances
     
  3. Methods for micronization of hydrophobic drugs

Pharmaceutical Manufacturing, Plasmid DNA

  1. Method of plasmid DNA production and purification

Pharmaceutical Manufacturing, Spray Drying

  1. Preservation of bioactive materials by spray drying
     
  2. Spray drying process control of drying kinetics
     
  3. Formulation for spray-drying large porous particles
     
  4. Process for producing nanometer particles by fluid bed spray-drying
     
  5. Stable spray-dried protein formulations
     
  6. Formulation for inhalation
     
  7. Formulation for spray-drying large porous particles
     
  8. Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition
     
  9. Process for preparing spray granules containing riboflavin
     
  10. Spray-dried microparticles and their use as therapeutic vehicles
     
  11. Spray drying process and compositions of fenofibrate
     
  12. Method of stabilizing biologically active substances
     
  13. Spray drying of macromolecules to produce inhaleable dry powders
     
  14. Spray-drying process for the preparation of microparticles
     
  15. Methods of spray-drying a drug and a hydrophobic amino acid

  16. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients

  17. Dry flowable polyoxin compositions
     
  18. Spray dried erythropoietin
     
  19. Microparticles and their use in wound therapy
     
  20. Method for producing water dispersible sterol formulations
     
  21. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
     
  22. Dispersible macromolecule compositions and methods for their preparation and use
     
  23. Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
     
  24. Spray-dried microparticles and their use as therapeutic vehicles
     
  25. Processes for spray drying hydrophobic drugs in organic solvent suspensions
     
  26. Spray dried polyol composition and method of making

Pharmaceutical Manufacturing, Supercritical Fluid

  1. Method and apparatus for producing particles using supercritical fluid
     
  2. Method for extraction and concentration of carotenoids using supercritical fluids
     
  3. Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique
     
  4. Method and apparatus for enhanced size reduction of particles using supercritical fluid liquefaction of materials
     
  5. Synthesis of polysuccinimide and copoly(succinimide-aspartate) in a supercritical fluid
     
  6. Biofunctional polymers prepared in supercritical fluid
     
  7. Method and apparatus for preparing taxol using supercritical fluid from source materials

Pharmaceutical Manufacturing, Vaccines

  1. Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
     
  2. Process for the maturation of dendritic cells and a vaccine
     
  3. Production of vaccines
     
  4. Large scale productions of virus antigen
     
  5. Isolated avian cell that expresses Vaccinia virus host range genes
     
  6. Method for the isolation of polysaccharides
     
  7. Production method of recombinant rotavirus structural proteins and vaccine composition
     
  8. Methods and interferon deficient substrates for the propagation of viruses
     
  9. Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
     
  10. Methods for enhancing the production of viral vaccines in cell culture

Pharmaceutical/Medical,  Polymers/Macromers

  1. Pulverulent, cross-linked polymers capable of absorbing aqueous liquids
     
  2. Interface-directed branched polymer transports and methods for producing same
     
  3. Temperature sensitive polymers
     
  4. Temperature and pH sensitive copolymers
     
  5. pH-sensitive block copolymers for pharmaceutical compositions
     
  6. Polyalkylene glycol viscosity-enhancing polymeric formulations
     
  7. Flexible thermal control composite
     
  8. Process of making a compound by forming a polymer from a template drug
     
  9. Chitosan and method of preparing chitosan
     
  10. Enzyme-catalyzed polycondensations
     
  11. In vivo use of water absorbent polymers
     
  12. Blend, cross-linkable poly(propylene fumarate) for immobilization and controlled drug delivery
     
  13. Polymers for delivering nitric oxide in vivo
     
  14. Process for cross-linking hyaluronic acid to polymers
     
  15. Slow release protein polymers
     
  16. Biofunctional polymers prepared in supercritical fluid
     
  17. Polyurethane film-forming dispersions in alcohol-water system
     
  18. Medicaments based on polymers composed of methacrylamide-modified gelatin
     
  19. Tetracarbon
     
  20. Biofunctional polymers prepared in supercritical fluid
     
  21. Water-swellable crosslinked polymer, its composition, and their production processes and uses
     
  22. Modified polymers containing poly(2-hydroxyethyl(meth)acrylate segment in the molecule
     
  23. Gels for encapsulation of biological materials
     
  24. Biologically-active polymers
     
  25. Hybrid silane dendrimer-star polymers
     
  26. Polymerizable biodegradable polymers including carbonate or dioxanone linkages
     
  27. Starburst conjugates
     
  28. Crosslinkable macromers bearing initiator groups
     
  29. pH-modified biocompatible monomer and polymer compositions
     
  30. Biodegradable copolymer containing .alpha.-hydroxy acid and .alpha.-amino acid units
     
  31. Antacid co-polymer of guanidine and polyethylenimine
     
  32. Chemical modification of repetitive polymers to enhance water solubility
     
  33. Disulfide-containing dendritic polymers
     
  34. Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same

Prevention, Drug Dependency

  1. Method to reduce the physiologic effects of drugs on mammals
     
  2. Impeding the extraction of active ingredients out of tablets

Proteomics

  1. Cysteine variants of interleukin-11
     
  2. Method for purifying recombinant proteins expressed as insoluble aggregates
     
  3. Polypeptide fingerprinting methods and bioinformatics database system

Quality Control

  1. Internal quality control
     
  2. Method and an industrial process for determining dose-level characteristics of a multiple unit system

Recombinant Technology

  1. Virus coat protein variants with self-subtracting properties
     
  2. Method of preparing cysteine mutants of human recombinant GM-CSF
     
  3. Methods and compositions for producing recombinant proteins using a gene for TRNA
     
  4. Recombinant lipidated PsaA protein, methods of preparation and use
     
  5. Method for refolding a protein
     
  6. Compositions and methods for producing recombinant proteins
     
  7. Method of producing recombinant DNA molecules
     
  8. Genetic screen for bioactive peptides
     
  9. Recombinant protein production in a human cell
     
  10. Mannitol induced promoter systems in bacterial host cells
     
  11. Recombinant biotin carboxylase domains for identification of Acetyle CoA carboxylase inhibitors
     
  12. Antibodies binding the TNF related protein, TNF-Y
     
  13. Pro1357 polypeptide
     
  14. Secreted and transmembrane polypeptides and nucleic acids encoding the same
     
  15. Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
     
  16. Recombinant protein production in a human cell
     
  17. Universal procedure for refolding recombinant proteins
     
  18. Bovine growth hormone recombinantly produced in E. coli
     
  19. Regulation of translation for recombinant protein production
     
  20. Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
     
  21. Recombinant soluble Fc receptors
    22.  
  22. Human voltage gated sodium channel .beta.1A subunit and methods of use
     
  23. Process for scaled-up production of recombinant proteins using transgenic plant suspension cultures
     
  24. Recombinant infectious laryngotracheitis virus and uses thereof
     
  25. Thermostable enzyme promoting the fidelity of thermostable DNA polymerases-for improvement of nucleic acid synthesis and amplification in vitro
     
  26. Enhanced in vitro recombinational cloning of using ribosomal proteins
     
  27. Production of human parathyroid hormone from microorganisms
     
  28. Method for generating recombinant DNA library using unidirectional single-stranded DNA fragments
     
  29. Modified DNA molecule, recombinant containing the same, and uses thereof
     
  30. Interleukin-2 mutein expressed from mammalian cells
     
  31. Recombinant mistletoe lectines
     
  32. Monoclonal antibody to the stabilizer peptide of the P64K antigen of Neisseria meningitidis
     
  33. Polypeptide-human galectin 15 and a polynucleotide encoding the same
     
  34. Method for purifying recombinant proteins expressed as insoluble aggregates
     
  35. Recombinant anti-tumor RNAse
     
  36. Means and methods for fibroblast-like or macrophage-like cell transduction
     
  37. Production method of recombinant rotavirus structural proteins and vaccine composition
     
  38. Methods and compositions for extracting proteins from cells
     
  39. Recombinant parainfluenza virus expression system and vaccines
     
  40. Methods for the administration of adenovirus p53
     
  41. Low oxygen affinity mutant hemoglobins
     
  42. Recombinant adenoviruses expressing interleukin-18 protein and gene therapy using them
     
  43. Regulated autocrine growth of mammalian cells
     
  44. Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
     
  45. Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof
     
  46. Phage-dependent superproduction of biologically active protein and peptides
     
  47. Expression of recombinant human acetylcholinesterase in transgenic plants
     
  48. Recombinant adenovirus
     
  49. Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
     
  50. Recombinant anti-CCR2 antibodies and methods of use therefor
     
  51. Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
     
  52. Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein
     
  53. Promoters for expressing genes in a fungal cell
     
  54. Recombinant human erythropoietin with advantageous glycosylation profile
     
  55. Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
     
  56. Penicillin binding protein from Streptococcus pneumoniae
     
  57. Process of microwave sterilization of culture media for selection of recombinant microorganisms
     
  58. Compartmentalization of recombinant polypeptides in host cells
     
  59. Metabolically activated recombinant viral vectors and methods for the preparation and use
     
  60. Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems
     
  61. IRAK3 polynucleotides
     
  62. Isolated and purified 12R-lipoxygenase protein and nucleic acids
     
  63. IgG-binding protein from Staphylococcus and nucleotide sequence encoding this protein
     
  64. Retroviral gene therapy vectors and therapeutic methods based thereon
     
  65. Recombinant alpha-fetoprotein hybrid cytotoxins for treating and diagnosing cancers
     
  66. Polyspecific binding molecules and uses thereof
     
  67. Recombinant trytophan mutants of influenza
     
  68. Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1)
     
  69. Recombiniant gamma interferons having enhanced stability and methods therefor
     
  70. Fusion proteins comprising coiled-coil structures derived of bovine IF1 ATPase inhibitor protein
     
  71. Recombinant Sef14 fimbrial protein from Salmonella
     
  72. IL-B30 proteins
     
  73. Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
     
  74. Regulated expression of recombinant proteins using RNA viruses
     
  75. Recombinant human papillomavirus vaccine expressed in transgenic plants
     
  76. Method for producing non-infectious recombinant picornavirus particles
     
  77. DNA encoding a human histamine receptor of the H3 subtype
     
  78. Recombinant AAV packaging systems
     
  79. Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
     
  80. Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter
     
  81. Anaerobe targeted enzyme-mediated prodrug therapy
     
  82. Method for producing recombinant virus

  83. Expression and purification of human interleukin-3 and muteins thereof

  84. Cytokine suppressive anti-inflammatory drug binding protein

  85. Prokaryotic polynucleotides polypeptides and their uses

  86. Therapy of cancer by insect cells containing recombinant baculovirus encoding genes 

  87. Neuronal uses of BMP-11
     
  88. Interleukin-1 receptor antagonist and recombinant production thereof
     
  89. Recombinant protein having bacteriophage endosialidase enzymatic activity
     
  90. Recombinant tryptophan mutants of influenza
     
  91. DNA encoding high affinity interleukin-4 muteins
     
  92. Recombinant human anti-Lewis Y antibodies
     
  93. Osteogenic devices
     
  94. Polypeptides displaying HBV antigenicity or hbv antigen specificity
     
  95. Anti-interleukin-1 receptor antagonist antibodies and uses thereof
     
  96. Formulations of recombinant papillomavirus vaccines
     
  97. Engineered cytotoxic ribonclease
     
  98. Immunoglobulin-like domains with increased half-lives
     
  99. Recombinant mycobacterial vaccine
     
  100. Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins
     
  101. Packaging systems for human recombinant adenovirus to be used in gene therapy
     
  102. Homologous sequence targeting in eukaryotic cells
     
  103. Production of somatic mosaicism in mammals using a recombinatorial substrate
     
  104. Recombinant immunogenic actinomycetale
     
  105. Multiple drug resistance gene atrD of Aspergillus nidulans
     
  106. Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
     
  107. Recombinant chimeric virus and uses thereof
     
  108. Methods for making modified recombinant vesiculoviruses
     
  109. Gene transfer for studying and treating a connective tissue of a mammalian host
     
  110. Phosphorylated fusion proteins

Research, Dermatological

  1. Epidermis/dermis equivalents and aged skin equivalents shaped therefrom

Research, Molecular Biology

  1. Nuclease inhibitor cocktail

Simulated, Fluid

  1. Simulated seminal fluid

Statistical/Data, Analysis/Presentaton

  1. Graphical user interface for display and analysis of biological sequence data
     
  2. Statistical deconvoluting of mixtures

Sterilization/Disinfection/Biocide

  1. Aqueous hydrogen peroxide for sterilization
     
  2. Compositions and methods for prion decontamination
     
  3. Stabilized hydrogen peroxide
     
  4. Disinfectant delivery system and method of providing alcohol-free disinfection
     
  5. Electronic management of sterilization process information
     
  6. Sterilization challenge specimen holder
     
  7. Method of providing alcohol-free disinfection
     
  8. Foamable iodine composition
     
  9. Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
     
  10. Pyrithione biocides enhanced by silver, copper, or zinc ions
     
  11. Aqueous disinfecting systems
     
  12. Application for hop acids as anti-microbial agents
     
  13. Biological indicator system to detect effectiveness of sterilization
     
  14. Light stabilized antimicrobial materials
     
  15. Enhanced activity alcohol-based antimicrobial compositions
     
  16. Methods for sterilizing cross-linked gelatin compositions
     
  17. Disinfectant and method of making
     
  18. Methods for sterilizing preparations containing albumin
     
  19. Antimicrobial surfaces
     
  20. Amino-acid iodine complex
     
  21. Method of testing for the presence of microorganisms in a gaseous environment comprising hydrogen peroxide
     
  22. Antibacterial agent
     
  23. Package for a pharmaceutical product and method of manufacturing and sterilizing the package
     
  24. Antibacterial agent
     
  25. Non-corrosive sterilant composition
     
  26. Alcohol-free anti-bacterial wipes
     
  27. Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation
     
  28. Stable hydrogen peroxide compositions, products and methods of use
     
  29. Microbicidal formulations and methods to control microorganisms
     
  30. Microbiostatic garment
     
  31. Composition containing molecular iodine
     
  32. Antibacterial compositions and method of using same
     
  33. Methods for sterilizing biological materials by irradiation over a temperature gradient
     
  34. Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol
     
  35. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil
     
  36. Methods for sterilizing cross-linked gelatin compositions
     
  37. Gentle-acting skin disinfectants
     
  38. Methods for sterilizing preparations of glycosidases
     
  39. Autoclavable pharmaceutical compositions containing a chelating agent
     
  40. Use of o-vanillin and o-vanillin/trolox combinations
     
  41. Methods for sterilizing preparations of digestive enzymes
     
  42. Multi-component, safe biocidal complex
     
  43. Methods for sterilizing biological materials by multiple rates
     
  44. Iodine/resin disinfectant and a procedure for the preparation thereof
     
  45. Method of sterilizing products
     
  46. Stabilized active bromine biocidal solutions
     
  47. Non-toxic antimicrobial compositions and methods of use
     
  48. Antimicrobial synthetic ion exchange resins
     
  49. Two-part disinfecting systems and compositions and methods related thereto
     
  50. Method of sterilizing
     
  51. Antimicrobial wipes which provide improved immediate germ reduction
     
  52. Human xenografts for microbicide testing and anatomical modeling
     
  53. Disinfectant composition
     
  54. Potentiation of biocide activity using a diethanolamide
     
  55. Device and method for testing biocidal efficacy of a liquid

  56. Enhanced antimicrobial composition

  57. Hydrogen peroxide disinfectant with increased activity

  58. Long-acting disinfectant and its preparation method

  59. Method of sterilizing
     
  60. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
     
  61. Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
     
  62. Non-staining topical iodine composition and method
     
  63. Method for inhibiting microbial adhesion on surfaces
     
  64. Antibacterial keyboard
     
  65. Stable glycerine iodine concentrate compositions
     
  66. Aqueous bactericidal compositions based on synergistic combination of linear alkylbenzenesulfonates and n-propanol
     
  67. Concentrated aqueous bromine solutions and their preparation
     
  68. Sterilization process for pharmaceutical suspensions
     
  69. Enhancement of antimicrobial peptide activity by metal ions
     
  70. Oxygen activatable formulations for disinfection or sterilization

Testing, Microbiological

  1. Design and selection of genetic targets for sequence resolved organism detection and identification
     
  2. Method of analyzing intestinal flora and analytical apparatus
     
  3. Means for qualitative and quantitative analysis of microbial populations potentially present in a sample
     
  4. System for detecting bacteria in blood, blood products, and fluids of tissues
     
  5. Methods for the detection, quantification and differentiation of infectious versus non-infectious pathogens in a sample

Transgenic/Phytopharmaceutical Plants

  1. Systems and methods for protein production
     
  2. Micropropagation and production of phytopharmaceutical plants
     
  3. Method of use of transgenic plant expressed antibodies
     
  4. Expression of recombinant human acetylcholinesterase in transgenic plants
     
  5. Opiumless and alkaloid-free non-narcotic opium poppy (Papaver somniferum) variety "Sujata"
     
  6. Metal-regulated transporters and uses therefor
     
  7. Recombinant human papillomavirus vaccine expressed in transgenic plants
     
  8. Oral immunization with transgenic plants

  9. Methods and products for controlling the immune response of a mammal to glutamic acid decarboxylase

Miscellaneous 

  1. Molecular motor
     
  2. Passaged neural stem cell-derived neuronal networks as sensing elements for detection of environmental threats
     
  3. Nanocrystal taggants
     
  4. Method and apparatus for determining target depth, brightness and size within a body region
     
  5. System and method for enhancing microscopic images of tissue
     
  6. Coronavirus-like particles comprising functionally deleted genomes
     
  7. Methods of reducing the nicotine content of tobacco plants and tobacco plants obtained thereby
     
  8. Method of forming vertebrate pancreas in vitro
     
  9. Analytical method for the determination of infant formula protein digestibility in vitro
     
  10. In vivo incorporation of unnatural amino acids
     
  11. Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
     
  12. Synthetic urine and method of manufacturing same
     
  13. Method of lethally sensitizing human and animal cells
     
  14. Method of screening for agents inhibiting chloride intracellular channels
     
  15. Microbiostatic garment
     
  16. Process for preparing non-hygroscopic sodium valproate composition
     
  17. Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone
     
  18. Classification of biological agents according to the spectral density signature of evoked changes in cellular electric potential

  19. Protein material for slow digestion and its use

  20. System of providing medical treatment
     
  21. Methods using cross linked protein crystal formulations as catalysts in organic solvents
     
  22. Beverage containing caffeine or theobromine and vinpocetine citrate for stimulating cerebral activity
     
  23. Swallowing-assistive drink
     
  24. Antibacterial keyboard
     
  25. Flash flow processing of thermoplastic polymers and products made therefrom
     
  26. Methods of inactivating bacteria including bacterial spores

 
     
[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ FDA Links ] [ FDA Warning Letters ] [ Pharm/Biotech Events ]
[ Newsletter Subscription ] [ Web Links ] [ Suggestions ] [ Site Map ]